However, recent studies indicate that inhibition of one PI3K isoform in breast cancer containing PTEN deficiency, PI3Kα mutation or HER2 amplification may lead to compensatory reactivation of another [29, 30]. This evidence concerns the gene PIK3CD and breast carcinoma.